李氏大药厂(00950)发布年度业绩股东应占溢利9193.8万港元同比减少1.2%

智通财经03-30

智通财经APP讯，李氏大药厂(00950)发布截至2025年12月31日止年度业绩，集团收益14.36亿港元，同比增长2.6%;股东应占溢利9193.8万港元，同比减少1.2%;每股盈利15.61港仙;拟派末期股息每股2.3港仙。公告称，公司拥有人应占纯利减少反映严峻市场环境及研发支出增加的合并影响，抵销了收益增长及销售费用减少所带来的裨益，导致纯利同比下滑。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2623318798?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-30 17:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623318798","market":"us","top_or_hot":-1,"title":"李氏大药厂(00950)发布年度业绩 股东应占溢利9193.8万港元 同比减少1.2%","media":"智通财经","content":"<div>\n<p>智通财经APP讯，李氏大药厂(00950)发布截至2025年12月31日止年度业绩，集团收益14.36亿港元，同比增长2.6%;股东应占溢利9193.8万港元，同比减少1.2%;每股盈利15.61港仙;拟派末期股息每股2.3港仙。公告称，公司拥有人应占纯利减少反映严峻市场环境及研发支出增加的合并影响，抵销了收益增长及销售费用减少所带来的裨益，导致纯利同比下滑。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1421792.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>李氏大药厂(00950)发布年度业绩 股东应占溢利9193.8万港元 同比减少1.2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n李氏大药厂(00950)发布年度业绩 股东应占溢利9193.8万港元 同比减少1.2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-30 17:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1421792.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，李氏大药厂(00950)发布截至2025年12月31日止年度业绩，集团收益14.36亿港元，同比增长2.6%;股东应占溢利9193.8万港元，同比减少1.2%;每股盈利15.61港仙;拟派末期股息每股2.3港仙。公告称，公司拥有人应占纯利减少反映严峻市场环境及研发支出增加的合并影响，抵销了收益增长及销售费用减少所带来的裨益，导致纯利同比下滑。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1421792.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1587","symbol_name":"次新股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1421792.html","article_id":"2623318798","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2623318798","pubTimestamp":1774862354,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，李氏大药厂(00950)发布截至2025年12月31日止年度业绩，集团收益14.36亿港元，同比增长2.6%;股东应占溢利9193.8万港元，同比减少1.2%;每股盈利15.61港仙;拟派末期股息每股2.3港仙。公告称，公司拥有人应占纯利减少反映严峻市场环境及研发支出增加的合并影响，抵销了收益增长及销售费用减少所带来的裨益，导致纯利同比下滑。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1587":"次新股","BK1574":"生物医药B类股","00950":"李氏大药厂","BK1583":"高瓴概念","06622":"兆科眼科-B","BK1191":"制药"},"translate_title":"Lee's Pharmaceuticals (00950) released its annual results. Profit attributable to shareholders was HK$91.938 million, a year-on-year decrease of 1.2%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06622":1.5,"00950":1.5},"content_text":"智通财经APP讯，李氏大药厂(00950)发布截至2025年12月31日止年度业绩，集团收益14.36亿港元，同比增长2.6%;股东应占溢利9193.8万港元，同比减少1.2%;每股盈利15.61港仙;拟派末期股息每股2.3港仙。公告称，公司拥有人应占纯利减少反映严峻市场环境及研发支出增加的合并影响，抵销了收益增长及销售费用减少所带来的裨益，导致纯利同比下滑。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2623318798","isCrawlerRequest":true}

李氏大药厂(00950)发布年度业绩 股东应占溢利9193.8万港元 同比减少1.2%

精彩评论

李氏大药厂(00950)发布年度业绩股东应占溢利9193.8万港元同比减少1.2%